Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients. 1989

D Torre, and M Broggini, and V Botta, and C Sampietro
Division of Infectious Diseases Regional Hospital and Foundation E. and S. Macchi, Varese, Italy.

Susceptible individuals of an institution for the mentally retarded (20 residents and six staff members) were vaccinated with Hevac B Pasteur (5 micrograms, months 0, 1, 2, 14). There were protective levels of anti-HBs in 75% of residents and 100% of staff members after 15 months from the first dose of the vaccine. After a 4-year follow-up period, there were persistent and protective levels of anti-HBs in 80% of residents, compared with 66% in staff members. In addition, no clinical hepatitis B infections were observed during this period.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D Torre, and M Broggini, and V Botta, and C Sampietro
October 1986, American journal of infection control,
D Torre, and M Broggini, and V Botta, and C Sampietro
August 1985, Hepato-gastroenterology,
D Torre, and M Broggini, and V Botta, and C Sampietro
September 1989, The Journal of infection,
D Torre, and M Broggini, and V Botta, and C Sampietro
July 1986, American journal of public health,
D Torre, and M Broggini, and V Botta, and C Sampietro
April 1977, JAMA,
D Torre, and M Broggini, and V Botta, and C Sampietro
January 1983, Scandinavian journal of infectious diseases. Supplementum,
D Torre, and M Broggini, and V Botta, and C Sampietro
January 1984, Hepatology (Baltimore, Md.),
D Torre, and M Broggini, and V Botta, and C Sampietro
February 1988, Vaccine,
D Torre, and M Broggini, and V Botta, and C Sampietro
February 1999, Vaccine,
Copied contents to your clipboard!